On April 11, 2026, SJ Corporation Limited made headlines as it secured approval from the Bombay Stock Exchange (BSE) to list 3.5 crore equity shares from its recent preferential issue. This pivotal moment follows an initial approval granted on March 10, 2026, and the completion of share allotment on March 20, 2026.
The preferential issue raised a substantial ₹42 crore for the company, with shares issued at a price of ₹12 each, which includes a premium of ₹11. This move is aimed at strengthening SJ Corporation’s financial position and attracting new promoters, a critical step given the company’s previous struggles.
Despite the optimism surrounding this approval, the current trading volume of SJ Corporation shares has been alarmingly low, averaging zero, which raises concerns about liquidity risk. The company operates in the Gems & Jewellery and Real Estate sectors, but its sales growth has been weak, and it has faced negative return on equity (ROE), indicating ongoing financial difficulties.
As the company prepares for trading, it is essential to note that further conditions must be met, including approval from the National Stock Exchange (NSE) and confirmation of share credit and lock-in periods. The timeline for meeting these regulatory requirements remains uncertain.
Moreover, while the recent capital raise is expected to boost the company’s trading volume, the actual impact on business performance is still unclear. Investors are keenly watching how quickly SJ Corporation can navigate these hurdles and leverage the funds raised to improve its financial health.
In the past year, SJ Corporation’s shares have seen a 40% increase, yet the trailing price-to-earnings (P/E) ratio stands at a staggering 123-130x, reflecting the market’s cautious sentiment towards the company’s future prospects.
As developments unfold, stakeholders are left to ponder the implications of this share exchange approval and the potential for SJ Corporation to turn its fortunes around in the competitive landscape of the stock market.
Details remain unconfirmed regarding the timeline for trading approval and the overall impact of the raised funds on the company’s performance.
